nodes	percent_of_prediction	percent_of_DWPC	metapath
Aprobarbital—GRIK2—Parkinson's disease	0.41	0.539	CbGaD
Aprobarbital—CHRNA4—Parkinson's disease	0.351	0.461	CbGaD
Aprobarbital—CHRNA4—superior cervical ganglion—Parkinson's disease	0.01	0.0969	CbGeAlD
Aprobarbital—CHRNA4—adrenal medulla—Parkinson's disease	0.00823	0.0795	CbGeAlD
Aprobarbital—GRIK2—cerebellar cortex—Parkinson's disease	0.00703	0.0679	CbGeAlD
Aprobarbital—GRIK2—telencephalic ventricle—Parkinson's disease	0.00409	0.0395	CbGeAlD
Aprobarbital—CHRNA4—autonomic nervous system—Parkinson's disease	0.00368	0.0356	CbGeAlD
Aprobarbital—CHRNA4—telencephalic ventricle—Parkinson's disease	0.00329	0.0317	CbGeAlD
Aprobarbital—CHRNA4—peripheral nervous system—Parkinson's disease	0.00266	0.0257	CbGeAlD
Aprobarbital—GRIK2—nerve—Parkinson's disease	0.00258	0.0249	CbGeAlD
Aprobarbital—GRIA2—hindbrain—Parkinson's disease	0.00214	0.0206	CbGeAlD
Aprobarbital—CHRNA4—nerve—Parkinson's disease	0.00207	0.02	CbGeAlD
Aprobarbital—GABRA6—hindbrain—Parkinson's disease	0.00206	0.0199	CbGeAlD
Aprobarbital—GRIK2—hindbrain—Parkinson's disease	0.00193	0.0186	CbGeAlD
Aprobarbital—CHRNA4—hindbrain—Parkinson's disease	0.00155	0.015	CbGeAlD
Aprobarbital—GABRA2—hindbrain—Parkinson's disease	0.00139	0.0134	CbGeAlD
Aprobarbital—GABRA1—hindbrain—Parkinson's disease	0.00134	0.013	CbGeAlD
Aprobarbital—GRIA2—embryo—Parkinson's disease	0.00134	0.0129	CbGeAlD
Aprobarbital—GRIA2—brainstem—Parkinson's disease	0.00122	0.0118	CbGeAlD
Aprobarbital—GABRA6—brainstem—Parkinson's disease	0.00118	0.0114	CbGeAlD
Aprobarbital—GRIA2—forebrain—Parkinson's disease	0.00118	0.0114	CbGeAlD
Aprobarbital—GABRA5—forebrain—Parkinson's disease	0.00111	0.0107	CbGeAlD
Aprobarbital—GRIK2—brainstem—Parkinson's disease	0.00111	0.0107	CbGeAlD
Aprobarbital—CHRFAM7A—forebrain—Parkinson's disease	0.00108	0.0104	CbGeAlD
Aprobarbital—GRIK2—forebrain—Parkinson's disease	0.00107	0.0103	CbGeAlD
Aprobarbital—GABRA4—forebrain—Parkinson's disease	0.00101	0.0097	CbGeAlD
Aprobarbital—CHRNA4—brainstem—Parkinson's disease	0.000889	0.00859	CbGeAlD
Aprobarbital—CHRNA7—forebrain—Parkinson's disease	0.00087	0.0084	CbGeAlD
Aprobarbital—CHRNA4—forebrain—Parkinson's disease	0.000858	0.00829	CbGeAlD
Aprobarbital—GABRA2—brainstem—Parkinson's disease	0.000796	0.00769	CbGeAlD
Aprobarbital—GRIA2—midbrain—Parkinson's disease	0.000781	0.00754	CbGeAlD
Aprobarbital—GRIK2—medulla oblongata—Parkinson's disease	0.000772	0.00745	CbGeAlD
Aprobarbital—GABRA1—brainstem—Parkinson's disease	0.000769	0.00743	CbGeAlD
Aprobarbital—GABRA2—forebrain—Parkinson's disease	0.000768	0.00742	CbGeAlD
Aprobarbital—GRIA2—spinal cord—Parkinson's disease	0.000762	0.00735	CbGeAlD
Aprobarbital—GABRA1—forebrain—Parkinson's disease	0.000742	0.00717	CbGeAlD
Aprobarbital—CHRNA7—cardiovascular system—Parkinson's disease	0.000736	0.0071	CbGeAlD
Aprobarbital—CHRNA4—cardiovascular system—Parkinson's disease	0.000726	0.00701	CbGeAlD
Aprobarbital—GRIK2—midbrain—Parkinson's disease	0.000705	0.00681	CbGeAlD
Aprobarbital—GRIK2—spinal cord—Parkinson's disease	0.000688	0.00664	CbGeAlD
Aprobarbital—GRIA2—head—Parkinson's disease	0.000677	0.00654	CbGeAlD
Aprobarbital—GABRA6—head—Parkinson's disease	0.000654	0.00631	CbGeAlD
Aprobarbital—GRIA2—nervous system—Parkinson's disease	0.000642	0.0062	CbGeAlD
Aprobarbital—GABRA5—head—Parkinson's disease	0.000634	0.00613	CbGeAlD
Aprobarbital—GABRA6—nervous system—Parkinson's disease	0.00062	0.00599	CbGeAlD
Aprobarbital—GRIA2—central nervous system—Parkinson's disease	0.000618	0.00597	CbGeAlD
Aprobarbital—CHRFAM7A—head—Parkinson's disease	0.000617	0.00596	CbGeAlD
Aprobarbital—GRIK2—head—Parkinson's disease	0.000611	0.0059	CbGeAlD
Aprobarbital—GRIA2—cerebellum—Parkinson's disease	0.000604	0.00583	CbGeAlD
Aprobarbital—GABRA5—nervous system—Parkinson's disease	0.000601	0.00581	CbGeAlD
Aprobarbital—GABRA6—central nervous system—Parkinson's disease	0.000597	0.00576	CbGeAlD
Aprobarbital—GABRA3—head—Parkinson's disease	0.000591	0.0057	CbGeAlD
Aprobarbital—CHRFAM7A—nervous system—Parkinson's disease	0.000585	0.00565	CbGeAlD
Aprobarbital—GABRA6—cerebellum—Parkinson's disease	0.000583	0.00563	CbGeAlD
Aprobarbital—GRIK2—nervous system—Parkinson's disease	0.00058	0.0056	CbGeAlD
Aprobarbital—GABRA5—central nervous system—Parkinson's disease	0.000579	0.00559	CbGeAlD
Aprobarbital—GABRA4—head—Parkinson's disease	0.000575	0.00556	CbGeAlD
Aprobarbital—CHRNA4—midbrain—Parkinson's disease	0.000567	0.00547	CbGeAlD
Aprobarbital—CHRFAM7A—central nervous system—Parkinson's disease	0.000563	0.00544	CbGeAlD
Aprobarbital—GABRA3—nervous system—Parkinson's disease	0.00056	0.00541	CbGeAlD
Aprobarbital—GRIK2—central nervous system—Parkinson's disease	0.000558	0.00539	CbGeAlD
Aprobarbital—CHRNA4—spinal cord—Parkinson's disease	0.000553	0.00534	CbGeAlD
Aprobarbital—GABRA4—nervous system—Parkinson's disease	0.000546	0.00527	CbGeAlD
Aprobarbital—GRIK2—cerebellum—Parkinson's disease	0.000546	0.00527	CbGeAlD
Aprobarbital—GABRA3—central nervous system—Parkinson's disease	0.000539	0.0052	CbGeAlD
Aprobarbital—GABRA1—medulla oblongata—Parkinson's disease	0.000536	0.00518	CbGeAlD
Aprobarbital—Butabarbital—GRIK2—Parkinson's disease	0.000526	0.0692	CrCbGaD
Aprobarbital—GABRA4—central nervous system—Parkinson's disease	0.000525	0.00507	CbGeAlD
Aprobarbital—GABRA4—cerebellum—Parkinson's disease	0.000513	0.00496	CbGeAlD
Aprobarbital—CHRNA7—head—Parkinson's disease	0.000498	0.00481	CbGeAlD
Aprobarbital—Butethal—GRIK2—Parkinson's disease	0.000498	0.0655	CrCbGaD
Aprobarbital—CHRNA4—head—Parkinson's disease	0.000491	0.00474	CbGeAlD
Aprobarbital—GRIA2—brain—Parkinson's disease	0.00049	0.00474	CbGeAlD
Aprobarbital—GABRA1—midbrain—Parkinson's disease	0.00049	0.00473	CbGeAlD
Aprobarbital—Butalbital—GRIK2—Parkinson's disease	0.000486	0.0639	CrCbGaD
Aprobarbital—GABRA1—spinal cord—Parkinson's disease	0.000478	0.00462	CbGeAlD
Aprobarbital—GABRA6—brain—Parkinson's disease	0.000474	0.00458	CbGeAlD
Aprobarbital—CHRNA7—nervous system—Parkinson's disease	0.000472	0.00456	CbGeAlD
Aprobarbital—Thiopental—GRIK2—Parkinson's disease	0.000469	0.0617	CrCbGaD
Aprobarbital—CHRNA4—nervous system—Parkinson's disease	0.000466	0.0045	CbGeAlD
Aprobarbital—Amobarbital—GRIK2—Parkinson's disease	0.000463	0.0609	CrCbGaD
Aprobarbital—GABRA5—brain—Parkinson's disease	0.00046	0.00444	CbGeAlD
Aprobarbital—CHRNA7—central nervous system—Parkinson's disease	0.000455	0.00439	CbGeAlD
Aprobarbital—Butabarbital—CHRNA4—Parkinson's disease	0.00045	0.0592	CrCbGaD
Aprobarbital—CHRNA4—central nervous system—Parkinson's disease	0.000449	0.00433	CbGeAlD
Aprobarbital—CHRFAM7A—brain—Parkinson's disease	0.000447	0.00432	CbGeAlD
Aprobarbital—GRIK2—brain—Parkinson's disease	0.000443	0.00428	CbGeAlD
Aprobarbital—GABRA2—head—Parkinson's disease	0.00044	0.00425	CbGeAlD
Aprobarbital—CHRNA4—cerebellum—Parkinson's disease	0.000438	0.00423	CbGeAlD
Aprobarbital—GABRA3—brain—Parkinson's disease	0.000428	0.00413	CbGeAlD
Aprobarbital—Butethal—CHRNA4—Parkinson's disease	0.000426	0.056	CrCbGaD
Aprobarbital—GABRA1—head—Parkinson's disease	0.000425	0.0041	CbGeAlD
Aprobarbital—GABRA4—brain—Parkinson's disease	0.000417	0.00403	CbGeAlD
Aprobarbital—GABRA2—nervous system—Parkinson's disease	0.000417	0.00403	CbGeAlD
Aprobarbital—Butalbital—CHRNA4—Parkinson's disease	0.000415	0.0547	CrCbGaD
Aprobarbital—Secobarbital—GRIK2—Parkinson's disease	0.000413	0.0543	CrCbGaD
Aprobarbital—GABRA1—nervous system—Parkinson's disease	0.000403	0.00389	CbGeAlD
Aprobarbital—GABRA2—central nervous system—Parkinson's disease	0.000401	0.00388	CbGeAlD
Aprobarbital—Thiopental—CHRNA4—Parkinson's disease	0.000401	0.0528	CrCbGaD
Aprobarbital—Amobarbital—CHRNA4—Parkinson's disease	0.000396	0.0521	CrCbGaD
Aprobarbital—GABRA2—cerebellum—Parkinson's disease	0.000392	0.00379	CbGeAlD
Aprobarbital—Pentobarbital—GRIK2—Parkinson's disease	0.000389	0.0512	CrCbGaD
Aprobarbital—GABRA1—central nervous system—Parkinson's disease	0.000388	0.00375	CbGeAlD
Aprobarbital—GABRA1—cerebellum—Parkinson's disease	0.000379	0.00366	CbGeAlD
Aprobarbital—CHRNA7—brain—Parkinson's disease	0.000361	0.00349	CbGeAlD
Aprobarbital—Talbutal—GRIK2—Parkinson's disease	0.000357	0.047	CrCbGaD
Aprobarbital—CHRNA4—brain—Parkinson's disease	0.000356	0.00344	CbGeAlD
Aprobarbital—Secobarbital—CHRNA4—Parkinson's disease	0.000353	0.0464	CrCbGaD
Aprobarbital—Pentobarbital—CHRNA4—Parkinson's disease	0.000333	0.0438	CrCbGaD
Aprobarbital—GABRA2—brain—Parkinson's disease	0.000319	0.00308	CbGeAlD
Aprobarbital—GABRA1—brain—Parkinson's disease	0.000308	0.00297	CbGeAlD
Aprobarbital—Talbutal—CHRNA4—Parkinson's disease	0.000306	0.0402	CrCbGaD
Aprobarbital—Phenobarbital—GRIK2—Parkinson's disease	0.000291	0.0383	CrCbGaD
Aprobarbital—Phenobarbital—CHRNA4—Parkinson's disease	0.000249	0.0328	CrCbGaD
Aprobarbital—Thiopental—CYP2E1—Parkinson's disease	0.000194	0.0256	CrCbGaD
Aprobarbital—GABRA4—Neuronal System—GRIK1—Parkinson's disease	0.00016	0.00126	CbGpPWpGaD
Aprobarbital—GABRA3—Orphan transporters—CYCS—Parkinson's disease	0.000159	0.00125	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000158	0.00124	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000158	0.00124	CbGpPWpGaD
Aprobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000158	0.00124	CbGpPWpGaD
Aprobarbital—GABRA2—Orphan transporters—CYCS—Parkinson's disease	0.000156	0.00123	CbGpPWpGaD
Aprobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000156	0.00122	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—SLC18A2—Parkinson's disease	0.000155	0.00122	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000155	0.00122	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000155	0.00122	CbGpPWpGaD
Aprobarbital—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000154	0.00121	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000153	0.0012	CbGpPWpGaD
Aprobarbital—GRIK2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000153	0.0012	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—GRIK1—Parkinson's disease	0.000153	0.0012	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.000152	0.00119	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—HSPA8—Parkinson's disease	0.000152	0.00119	CbGpPWpGaD
Aprobarbital—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000152	0.00119	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000152	0.00119	CbGpPWpGaD
Aprobarbital—GRIK2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000151	0.00119	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—CHRNA4—Parkinson's disease	0.000151	0.00118	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.00015	0.00118	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—DLG1—Parkinson's disease	0.000149	0.00117	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000147	0.00116	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000147	0.00116	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—BDNF—Parkinson's disease	0.000145	0.00114	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000144	0.00113	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—DLG4—Parkinson's disease	0.000143	0.00112	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000142	0.00112	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—GRIK1—Parkinson's disease	0.000142	0.00112	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—GRIN2B—Parkinson's disease	0.000139	0.0011	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—GRIK1—Parkinson's disease	0.000139	0.0011	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000139	0.00109	CbGpPWpGaD
Aprobarbital—CHRNA7—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000139	0.00109	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—HSPA8—Parkinson's disease	0.000138	0.00109	CbGpPWpGaD
Aprobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000138	0.00109	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000138	0.00108	CbGpPWpGaD
Aprobarbital—CHRNA7—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000138	0.00108	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000138	0.00108	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—GRIK2—Parkinson's disease	0.000138	0.00108	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—SLC6A3—Parkinson's disease	0.000137	0.00108	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000137	0.00108	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—GRIK1—Parkinson's disease	0.000137	0.00108	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000137	0.00108	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	0.000137	0.00108	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000136	0.00107	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—GRIK2—Parkinson's disease	0.000136	0.00107	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000136	0.00107	CbGpPWpGaD
Aprobarbital—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000135	0.00106	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000135	0.00106	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000135	0.00106	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000135	0.00106	CbGpPWpGaD
Aprobarbital—GABRA1—Orphan transporters—CYCS—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—SLC18A2—Parkinson's disease	0.000133	0.00105	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000133	0.00104	CbGpPWpGaD
Aprobarbital—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000133	0.00104	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA4—Parkinson's disease	0.000132	0.00104	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	0.000132	0.00104	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—SLC18A2—Parkinson's disease	0.000132	0.00103	CbGpPWpGaD
Aprobarbital—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.00013	0.00102	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—DLG4—Parkinson's disease	0.00013	0.00102	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—GRIK2—Parkinson's disease	0.00013	0.00102	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—NGF—Parkinson's disease	0.000129	0.00101	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—GRIN2B—Parkinson's disease	0.000127	0.000996	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—CHRNA4—Parkinson's disease	0.000127	0.000996	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000126	0.000991	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—SLC18A2—Parkinson's disease	0.000126	0.000986	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—SLC6A3—Parkinson's disease	0.000125	0.000982	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000125	0.000979	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CHRNA4—Parkinson's disease	0.000121	0.000952	CbGpPWpGaD
Aprobarbital—Phenobarbital—CYP2E1—Parkinson's disease	0.000121	0.0159	CrCbGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000121	0.000948	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—GRIK2—Parkinson's disease	0.000121	0.000948	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000119	0.000931	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—GRIK2—Parkinson's disease	0.000119	0.000931	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000118	0.00093	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000118	0.00093	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000118	0.00093	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—NGF—Parkinson's disease	0.000117	0.000921	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—SLC18A2—Parkinson's disease	0.000117	0.000918	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000117	0.000918	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—COMT—Parkinson's disease	0.000117	0.000918	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—GRIK1—Parkinson's disease	0.000117	0.000918	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—HTR1A—Parkinson's disease	0.000117	0.000917	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000117	0.000916	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	0.000117	0.000915	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—GRIK2—Parkinson's disease	0.000117	0.000915	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000116	0.000914	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000116	0.000914	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—HSPA8—Parkinson's disease	0.000116	0.000913	CbGpPWpGaD
Aprobarbital—GRIK2—Neuronal System—MAOA—Parkinson's disease	0.000116	0.000911	CbGpPWpGaD
Aprobarbital—GRIA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000116	0.000909	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000116	0.000909	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—TAC1—Parkinson's disease	0.000115	0.000903	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—SLC18A2—Parkinson's disease	0.000115	0.000902	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	0.000114	0.000898	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	0.000114	0.000898	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000114	0.000897	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000114	0.000896	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—DLG4—Parkinson's disease	0.000114	0.000893	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—COMT—Parkinson's disease	0.000113	0.000888	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—SLC18A2—Parkinson's disease	0.000113	0.000886	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—HSPA8—Parkinson's disease	0.000113	0.000885	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.000113	0.000885	CbGpPWpGaD
Aprobarbital—CHRNA4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	0.000112	0.000882	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	0.000112	0.000877	CbGpPWpGaD
Aprobarbital—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIN2B—Parkinson's disease	0.000111	0.000873	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000111	0.000869	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—DLG4—Parkinson's disease	0.000109	0.000857	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000109	0.000854	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	0.000107	0.000839	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—GRIN2B—Parkinson's disease	0.000107	0.000837	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—COMT—Parkinson's disease	0.000106	0.000835	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—DLG4—Parkinson's disease	0.000106	0.000831	CbGpPWpGaD
Aprobarbital—CHRNA7—Neuronal System—MAOA—Parkinson's disease	0.000106	0.000829	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—CHRNA4—Parkinson's disease	0.000105	0.000828	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—SLC6A3—Parkinson's disease	0.000105	0.000825	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—CHRNA4—Parkinson's disease	0.000104	0.000818	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000104	0.000816	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—GRIN2B—Parkinson's disease	0.000103	0.000812	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.000102	0.000801	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—SLC6A3—Parkinson's disease	0.000102	0.0008	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	0.000102	0.000797	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—TH—Parkinson's disease	0.0001	0.000789	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—DLG4—Parkinson's disease	0.0001	0.000787	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	0.0001	0.000786	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.97e-05	0.000783	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—CHRNA4—Parkinson's disease	9.94e-05	0.000781	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—GRIK2—Parkinson's disease	9.94e-05	0.00078	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.83e-05	0.000772	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	9.8e-05	0.00077	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—TRPM7—Parkinson's disease	9.75e-05	0.000766	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—ATP1A3—Parkinson's disease	9.75e-05	0.000766	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—COMT—Parkinson's disease	9.7e-05	0.000762	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—HSPA8—Parkinson's disease	9.67e-05	0.000759	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	9.66e-05	0.000758	CbGpPWpGaD
Aprobarbital—GABRA6—Transmission across Chemical Synapses—MAOA—Parkinson's disease	9.63e-05	0.000756	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—SLC18A2—Parkinson's disease	9.62e-05	0.000756	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—COMT—Parkinson's disease	9.58e-05	0.000752	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—HSPA8—Parkinson's disease	9.55e-05	0.00075	CbGpPWpGaD
Aprobarbital—GABRA4—Transmission across Chemical Synapses—MAOA—Parkinson's disease	9.51e-05	0.000747	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—CHRNA4—Parkinson's disease	9.25e-05	0.000727	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—HSPA8—Parkinson's disease	9.11e-05	0.000715	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—CHRNA4—Parkinson's disease	9.09e-05	0.000714	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—DLG4—Parkinson's disease	9.07e-05	0.000713	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—DLG4—Parkinson's disease	8.96e-05	0.000704	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—COMT—Parkinson's disease	8.94e-05	0.000702	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—CHRNA4—Parkinson's disease	8.93e-05	0.000701	CbGpPWpGaD
Aprobarbital—GRIA2—Neuronal System—MAOA—Parkinson's disease	8.87e-05	0.000697	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—GRIN2B—Parkinson's disease	8.87e-05	0.000696	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—GRIN2B—Parkinson's disease	8.76e-05	0.000688	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—SLC6A3—Parkinson's disease	8.74e-05	0.000686	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—COMT—Parkinson's disease	8.67e-05	0.000681	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—SLC6A3—Parkinson's disease	8.63e-05	0.000678	CbGpPWpGaD
Aprobarbital—CHRNA4—Neuronal System—MAOA—Parkinson's disease	8.6e-05	0.000676	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—DLG4—Parkinson's disease	8.55e-05	0.000671	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—COMT—Parkinson's disease	8.51e-05	0.000668	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—HSPA8—Parkinson's disease	8.48e-05	0.000666	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—MAOA—Parkinson's disease	8.48e-05	0.000666	CbGpPWpGaD
Aprobarbital—GABRA5—Transmission across Chemical Synapses—MAOA—Parkinson's disease	8.45e-05	0.000664	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—COMT—Parkinson's disease	8.36e-05	0.000656	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—GRIN2B—Parkinson's disease	8.36e-05	0.000656	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—HSPA8—Parkinson's disease	8.33e-05	0.000654	CbGpPWpGaD
Aprobarbital—GABRA3—Transmission across Chemical Synapses—MAOA—Parkinson's disease	8.3e-05	0.000652	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—SLC6A3—Parkinson's disease	8.24e-05	0.000647	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—COMT—Parkinson's disease	8.21e-05	0.000645	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—HSPA8—Parkinson's disease	8.19e-05	0.000643	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—BDNF—Parkinson's disease	8.18e-05	0.000643	CbGpPWpGaD
Aprobarbital—GABRA2—Transmission across Chemical Synapses—MAOA—Parkinson's disease	8.15e-05	0.00064	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	8.12e-05	0.000638	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	8.1e-05	0.000636	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—DLG4—Parkinson's disease	7.96e-05	0.000625	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—DLG4—Parkinson's disease	7.82e-05	0.000614	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—GRIN2B—Parkinson's disease	7.78e-05	0.000611	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—DLG4—Parkinson's disease	7.68e-05	0.000603	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—SLC6A3—Parkinson's disease	7.67e-05	0.000602	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—GRIN2B—Parkinson's disease	7.64e-05	0.0006	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—CHRNA4—Parkinson's disease	7.61e-05	0.000598	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—SLC6A3—Parkinson's disease	7.53e-05	0.000591	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—GRIN2B—Parkinson's disease	7.51e-05	0.00059	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—COMT—Parkinson's disease	7.43e-05	0.000584	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—SLC6A3—Parkinson's disease	7.4e-05	0.000581	CbGpPWpGaD
Aprobarbital—GABRA6—Neuronal System—MAOA—Parkinson's disease	7.38e-05	0.000579	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—COMT—Parkinson's disease	7.34e-05	0.000576	CbGpPWpGaD
Aprobarbital—GABRA4—Neuronal System—MAOA—Parkinson's disease	7.29e-05	0.000572	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—NGF—Parkinson's disease	7.26e-05	0.00057	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—CASP3—Parkinson's disease	7.26e-05	0.00057	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.17e-05	0.000563	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	7.08e-05	0.000556	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—COMT—Parkinson's disease	7e-05	0.00055	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—HSPA8—Parkinson's disease	6.98e-05	0.000548	CbGpPWpGaD
Aprobarbital—GABRA1—Transmission across Chemical Synapses—MAOA—Parkinson's disease	6.95e-05	0.000546	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—HTR2A—Parkinson's disease	6.91e-05	0.000543	CbGpPWpGaD
Aprobarbital—GRIA2—BDNF signaling pathway—MAPK8—Parkinson's disease	6.67e-05	0.000524	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	6.62e-05	0.00052	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	6.6e-05	0.000519	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—CP—Parkinson's disease	6.59e-05	0.000518	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—DLG4—Parkinson's disease	6.55e-05	0.000514	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—COMT—Parkinson's disease	6.52e-05	0.000512	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—CP—Parkinson's disease	6.51e-05	0.000511	CbGpPWpGaD
Aprobarbital—GABRA5—Neuronal System—MAOA—Parkinson's disease	6.47e-05	0.000508	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—COMT—Parkinson's disease	6.4e-05	0.000503	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—GRIN2B—Parkinson's disease	6.4e-05	0.000503	CbGpPWpGaD
Aprobarbital—GABRA3—Neuronal System—MAOA—Parkinson's disease	6.36e-05	0.000499	CbGpPWpGaD
Aprobarbital—Phenobarbital—ABCB1—Parkinson's disease	6.34e-05	0.00834	CrCbGaD
Aprobarbital—GABRA1—Neuronal System—SLC6A3—Parkinson's disease	6.31e-05	0.000496	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—COMT—Parkinson's disease	6.29e-05	0.000494	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.29e-05	0.000494	CbGpPWpGaD
Aprobarbital—GABRA2—Neuronal System—MAOA—Parkinson's disease	6.25e-05	0.000491	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.17e-05	0.000485	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	6.07e-05	0.000476	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—TNF—Parkinson's disease	5.89e-05	0.000463	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—CP—Parkinson's disease	5.79e-05	0.000454	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—CP—Parkinson's disease	5.68e-05	0.000446	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—CP—Parkinson's disease	5.58e-05	0.000438	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—COMT—Parkinson's disease	5.37e-05	0.000421	CbGpPWpGaD
Aprobarbital—GABRA1—Neuronal System—MAOA—Parkinson's disease	5.33e-05	0.000418	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC18A2—Parkinson's disease	5.17e-05	0.000406	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—TNF—Parkinson's disease	4.8e-05	0.000377	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—CP—Parkinson's disease	4.76e-05	0.000374	CbGpPWpGaD
Aprobarbital—CHRNA7—SIDS Susceptibility Pathways—IL6—Parkinson's disease	4.75e-05	0.000373	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.7e-05	0.000369	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.64e-05	0.000364	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.51e-05	0.000354	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—CYCS—Parkinson's disease	4.45e-05	0.00035	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.12e-05	0.000324	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL1B—Parkinson's disease	4.1e-05	0.000322	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—CASP3—Parkinson's disease	4.09e-05	0.000321	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	4.05e-05	0.000318	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.98e-05	0.000312	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.96e-05	0.000311	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.92e-05	0.000308	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.89e-05	0.000305	CbGpPWpGaD
Aprobarbital—CHRNA4—SIDS Susceptibility Pathways—IL6—Parkinson's disease	3.88e-05	0.000304	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.87e-05	0.000304	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.82e-05	0.0003	CbGpPWpGaD
Aprobarbital—GABRA6—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.76e-05	0.000296	CbGpPWpGaD
Aprobarbital—GABRA4—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.72e-05	0.000292	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.44e-05	0.00027	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—SLC6A3—Parkinson's disease	3.39e-05	0.000266	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.38e-05	0.000265	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	3.32e-05	0.000261	CbGpPWpGaD
Aprobarbital—GABRA5—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.3e-05	0.000259	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—CYCS—Parkinson's disease	3.26e-05	0.000256	CbGpPWpGaD
Aprobarbital—GABRA3—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.24e-05	0.000255	CbGpPWpGaD
Aprobarbital—GABRA2—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	3.19e-05	0.00025	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—TNF—Parkinson's disease	2.97e-05	0.000234	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—HMOX1—Parkinson's disease	2.83e-05	0.000222	CbGpPWpGaD
Aprobarbital—GABRA1—Transmembrane transport of small molecules—ABCB1—Parkinson's disease	2.72e-05	0.000213	CbGpPWpGaD
Aprobarbital—GABRA1—SIDS Susceptibility Pathways—IL6—Parkinson's disease	2.4e-05	0.000188	CbGpPWpGaD
